Table 2 List of patients with gene fusions
| Risk group | ID | Sex | Age | Stage | Pathology | Chromosomal abnormality | Event | Fusion | ||
|---|---|---|---|---|---|---|---|---|---|---|
| High risk | N_SMC_001 | M | 3.8 | Metastatic | GNB | 11q | Recur/Dead | LUC7L3:KLC2 | ||
| N_SMC_006 | M | 3.1 | Metastatic | PD | 11q | Recur | CNTNAP4:RAB11FIP4 | |||
| N_SMC_011 | M | 3.3 | Metastatic | GNB |
CCDC32:CBX3* SAMD5:SASH1$ HLA-C:HLA-A L1RAPL1:REPS2 | |||||
| N_SMC_017 | M | 2.3 | Metastatic | D | 11q | 17q | PPFIA1:GSDMA | |||
| N_SMC_046 | M | 5.3 | Metastatic | PD | 1p | RALGPS2:DNAJC8 | ||||
| N_SMC_049 | M | 6.1 | Metastatic | PD | 11q | RPN1:CCDC58 | ||||
| N_SMC_070 | F | 4.6 | Metastatic | UD | 17q | FBXL7:CDKN3 | ||||
| N_SMC_076 | M | 3.8 | Metastatic | PD | 1p | 11q | 17q | HP1BP3:NUP85 | ||
| MED8:ELOVL1 | ||||||||||
| Non-high risk | N_SMC_003 | M | 10 | Localized | GNB | 1p | CCDC32:CBX3* | |||
| N_SMC_026 | F | 4.1 | Localized | GNB | CCDC32:CBX3* | |||||
| N_SMC_034 | F | 2.6 | Localized | D | 17q |
CCDC32:CBX3* KCNH7:MAP3K19 PPP6R2:ANKIB1 | ||||
| N_SMC_060 | M | 0.1 | Localized | D | 11q | MX1:FAM3B | ||||
| N_SMC_085 | F | 2.1 | Localized | GNB | 17q | CCDC32:CBX3* | ||||
| N_SMC_089 | M | 3.5 | Localized | GNB | SAMD5:SASH1$ | |||||
| N_SMC_093 | F | 6.4 | Localized | GNB | SAMD5:SASH1$ | |||||